GlassScriptPhysician profile
Bianka Eperjesiova
NPI 1871987446
$260,445.54
in general payments reported to CMS, 2019-2025
25 companies · $110K in 2025
The $110K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,060 · 2020: $857 · 2021: $2,436 · 2022: $8,392 · 2023: $32K · 2024: $103K · 2025: $110K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $126K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $61K · Travel and Lodging: $37K · Food and Beverage: $12K · Consulting Fee: $8,750 · Gift: $32.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $126,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $60,500.00 |
| Travel and Lodging | $37,384.16 |
| Food and Beverage | $12,034.94 |
| Consulting Fee | $8,750.00 |
| Gift | $32.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $241,010.23 | 2021-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Siemens Medical Solutions USA, INC. | $8,874.91 | 2025 | |
| Olympus Corporation of The Americas | $2,349.23 | 2019-2022 | |
| Steris Corporation | $1,523.10 | 2023 | |
| Pinnacle Biologics, INC | $1,485.06 | 2021 | |
| Pulmonx Corporation | $1,312.26 | 2020-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Galvanize Therapeutics, INC | $1,286.99 | 2025 | Aliya System |
| Becton, Dickinson and Company | $703.03 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $519.03 | 2019-2021 | |
| Insmed, INC. | $199.73 | 2019-2020 | |
| Bard Access Systems, INC. | $158.97 | 2019 | |
| United Therapeutics Corporation | $145.35 | 2019 | |
| Glaxosmithkline, LLC. | $130.34 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $109.25 | 2019 | |
| Mallinckrodt Enterprises LLC | $99.06 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $92.10 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $92.09 | 2019-2020 | |
| Grifols USA, LLC | $91.25 | 2021 | |
| Csl Behring | $77.24 | 2019-2020 | |
| Erbe USA INC | $75.00 | 2025 | Cryo2 |
| Harmony Biosciences LLC | $61.63 | 2020-2021 | |
| Circassia INC. | $13.89 | 2019 | |
| Mylan Specialty L.P. | $12.88 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.68 | 2019 | |
| Advanced Respiratory, INC | $11.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bianka Eperjesiova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.